180 related articles for article (PubMed ID: 25408417)
1. Vasculature-specific MRI reveals differential anti-angiogenic effects of a biomimetic peptide in an orthotopic breast cancer model.
Kim E; Lee E; Plummer C; Gil S; Popel AS; Pathak AP
Angiogenesis; 2015 Apr; 18(2):125-36. PubMed ID: 25408417
[TBL] [Abstract][Full Text] [Related]
2. Multiparametric characterization of response to anti-angiogenic therapy using USPIO contrast-enhanced MRI in combination with dynamic contrast-enhanced MRI.
Kim J; Kim E; Euceda LR; Meyer DE; Langseth K; Bathen TF; Moestue SA; Huuse EM
J Magn Reson Imaging; 2018 Jun; 47(6):1589-1600. PubMed ID: 29205621
[TBL] [Abstract][Full Text] [Related]
3. Anti-vascular effects of the cytosolic phospholipase A2 inhibitor AVX235 in a patient-derived basal-like breast cancer model.
Kim E; Tunset HM; Cebulla J; Vettukattil R; Helgesen H; Feuerherm AJ; Engebråten O; Mælandsmo GM; Johansen B; Moestue SA
BMC Cancer; 2016 Mar; 16():191. PubMed ID: 26951085
[TBL] [Abstract][Full Text] [Related]
4. Development of a biomimetic peptide derived from collagen IV with anti-angiogenic activity in breast cancer.
Rosca EV; Koskimaki JE; Pandey NB; Wolff AC; Popel AS
Cancer Biol Ther; 2011 Nov; 12(9):808-17. PubMed ID: 21878750
[TBL] [Abstract][Full Text] [Related]
5. Assessing breast cancer angiogenesis in vivo: which susceptibility contrast MRI biomarkers are relevant?
Kim E; Cebulla J; Ward BD; Rhie K; Zhang J; Pathak AP
Magn Reson Med; 2013 Oct; 70(4):1106-16. PubMed ID: 23225578
[TBL] [Abstract][Full Text] [Related]
6. Phase contrast MRI is an early marker of micrometastatic breast cancer development in the rat brain.
Budde MD; Gold E; Jordan EK; Smith-Brown M; Frank JA
NMR Biomed; 2012 May; 25(5):726-36. PubMed ID: 21954124
[TBL] [Abstract][Full Text] [Related]
7. Study of diffusion-weighted magnetic resonance imaging in the evaluation of the response to AAV2-VEGF-Trap neoadjuvant treatment in a triple-negative breast cancer animal model.
Li J; Zhu P; Wang L; Yang L; Zou L; Gao F
Cancer Med; 2019 Apr; 8(4):1594-1603. PubMed ID: 30900382
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the Response of Intracranial Xenografts to VEGF Signaling Inhibition Using Multiparametric MRI.
Boult JKR; Box G; Vinci M; Perryman L; Eccles SA; Jones C; Robinson SP
Neoplasia; 2017 Sep; 19(9):684-694. PubMed ID: 28780387
[TBL] [Abstract][Full Text] [Related]
9. Imaging biomarkers guided anti-angiogenic therapy for malignant gliomas.
Kong Z; Yan C; Zhu R; Wang J; Wang Y; Wang Y; Wang R; Feng F; Ma W
Neuroimage Clin; 2018; 20():51-60. PubMed ID: 30069427
[TBL] [Abstract][Full Text] [Related]
10. Anti-angiogenic Effects of Bumetanide Revealed by DCE-MRI with a Biodegradable Macromolecular Contrast Agent in a Colon Cancer Model.
Malamas AS; Jin E; Zhang Q; Haaga J; Lu ZR
Pharm Res; 2015 Sep; 32(9):3029-43. PubMed ID: 25840948
[TBL] [Abstract][Full Text] [Related]
11. Angiogenic role of miR-20a in breast cancer.
Luengo-Gil G; Gonzalez-Billalabeitia E; Perez-Henarejos SA; Navarro Manzano E; Chaves-Benito A; Garcia-Martinez E; Garcia-Garre E; Vicente V; Ayala de la Peña F
PLoS One; 2018; 13(4):e0194638. PubMed ID: 29617404
[TBL] [Abstract][Full Text] [Related]
12. Multivoxel ¹H MR spectroscopy is superior to contrast-enhanced MRI for response assessment after anti-angiogenic treatment of orthotopic human glioma xenografts and provides handles for metabolic targeting.
Hamans B; Navis AC; Wright A; Wesseling P; Heerschap A; Leenders W
Neuro Oncol; 2013 Dec; 15(12):1615-24. PubMed ID: 24158109
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of drug mechanism and efficacy of a novel anti-angiogenic agent, TTAC-0001, using multi-modality bioimaging in a mouse breast cancer orthotopic model.
Kim J; Choi SH; Ham SJ; Cho YC; Lee SI; Kang J; Woo DC; Lee WS; Yoo JS; Kim KW; Choi Y
PLoS One; 2018; 13(1):e0187063. PubMed ID: 29370209
[TBL] [Abstract][Full Text] [Related]
14. Monitoring the development of xenograft triple-negative breast cancer models using diffusion-weighted magnetic resonance imaging.
Stephen RM; Pagel MD; Brown K; Baker AF; Meuillet EJ; Gillies RJ
Exp Biol Med (Maywood); 2012 Nov; 237(11):1273-80. PubMed ID: 23239438
[TBL] [Abstract][Full Text] [Related]
15. In vivo "MRI phenotyping" reveals changes in extracellular matrix transport and vascularization that mediate VEGF-driven increase in breast cancer metastasis.
Pathak AP; McNutt S; Shah T; Wildes F; Raman V; Bhujwalla ZM
PLoS One; 2013; 8(5):e63146. PubMed ID: 23650550
[TBL] [Abstract][Full Text] [Related]
16. Anti-angiogenic therapy affects the relationship between tumor vascular structure and function: A correlation study between micro-computed tomography angiography and dynamic contrast enhanced MRI.
Kim E; Kim J; Maelandsmo GM; Johansen B; Moestue SA
Magn Reson Med; 2017 Oct; 78(4):1513-1522. PubMed ID: 27888545
[TBL] [Abstract][Full Text] [Related]
17. Calcitriol reduces thrombospondin-1 and increases vascular endothelial growth factor in breast cancer cells: implications for tumor angiogenesis.
García-Quiroz J; Rivas-Suárez M; García-Becerra R; Barrera D; Martínez-Reza I; Ordaz-Rosado D; Santos-Martinez N; Villanueva O; Santos-Cuevas CL; Avila E; Gamboa-Domínguez A; Halhali A; Larrea F; Díaz L
J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt A():215-22. PubMed ID: 24120914
[TBL] [Abstract][Full Text] [Related]
18. MRI monitoring of tumor response following angiogenesis inhibition in an experimental human breast cancer model.
Turetschek K; Preda A; Floyd E; Shames DM; Novikov V; Roberts TP; Wood JM; Fu Y; Carter WO; Brasch RC
Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):448-55. PubMed ID: 12722742
[TBL] [Abstract][Full Text] [Related]
19. Preclinical evaluation of tumor microvascular response to a novel antiangiogenic/antitumor agent RO0281501 by dynamic contrast-enhanced MRI at 1.5 T.
Muruganandham M; Lupu M; Dyke JP; Matei C; Linn M; Packman K; Kolinsky K; Higgins B; Koutcher JA
Mol Cancer Ther; 2006 Aug; 5(8):1950-7. PubMed ID: 16928815
[TBL] [Abstract][Full Text] [Related]
20. Sensitivity of MRI tumor biomarkers to VEGFR inhibitor therapy in an orthotopic mouse glioma model.
Farrar CT; Kamoun WS; Ley CD; Kim YR; Catana C; Kwon SJ; Rosen BR; Jain RK; Sorensen AG
PLoS One; 2011 Mar; 6(3):e17228. PubMed ID: 21390238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
